Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Common Equity (2016 - 2025)

INVO Fertility (IVF) has disclosed Common Equity for 15 consecutive years, with $5.8 million as the latest value for Q3 2025.

  • Quarterly Common Equity rose 25184.59% to $5.8 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $5.8 million through Sep 2025, up 25184.59% year-over-year, with the annual reading at $12.7 million for FY2024, 1327.77% up from the prior year.
  • Common Equity for Q3 2025 was $5.8 million at INVO Fertility, up from $2.6 million in the prior quarter.
  • The five-year high for Common Equity was $12.7 million in Q4 2024, with the low at -$1.7 million in Q2 2023.
  • Average Common Equity over 5 years is $2.9 million, with a median of $2.4 million recorded in 2021.
  • The sharpest move saw Common Equity crashed 150.81% in 2023, then soared 32744.56% in 2025.
  • Over 5 years, Common Equity stood at $7.3 million in 2021, then plummeted by 113.37% to -$977612.0 in 2022, then skyrocketed by 191.33% to $892825.0 in 2023, then soared by 1327.77% to $12.7 million in 2024, then tumbled by 54.12% to $5.8 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $5.8 million, $2.6 million, and $3.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.